Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum
- PMID: 25877390
- DOI: 10.1007/s00436-015-4460-9
Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum
Abstract
Although miltefosine (MIL) has only recently been positioned as a first-line therapeutic option for visceral leishmaniasis, field reports note an increasing trend in treatment failures. Study of laboratory selected MIL-resistant strains is needed in the absence of confirmed resistant clinical isolates. In contrast to promastigotes, experimental in vitro selection of MIL-resistance on intracellular amastigotes has not yet been documented. This study reports for the first time the selection of MIL-resistance in Leishmania infantum LEM3323, a strain which clearly shows active intracellular replication. Starting from the hypothesis that active multiplication may be essential in the resistance selection process; several other L. infantum strains were evaluated. Although strain LEM5269 showed only marginally lower intracellular multiplication, selection for resistance failed, as was also the case for several other strains showing poor or no intracellular replication. These results suggest that intracellular multiplication may not be an absolute prerequisite for the outcome of experimental in vitro MIL-resistance selection in clinical field isolates.
Similar articles
-
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes.PLoS One. 2016 Apr 28;11(4):e0154101. doi: 10.1371/journal.pone.0154101. eCollection 2016. PLoS One. 2016. PMID: 27123924 Free PMC article.
-
Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.J Antimicrob Chemother. 2016 Jul;71(7):1914-21. doi: 10.1093/jac/dkw096. Epub 2016 Apr 15. J Antimicrob Chemother. 2016. PMID: 27084919
-
Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis.Int J Parasitol Drugs Drug Resist. 2019 Dec;11:1-7. doi: 10.1016/j.ijpddr.2019.09.003. Epub 2019 Sep 10. Int J Parasitol Drugs Drug Resist. 2019. PMID: 31525614 Free PMC article.
-
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.Drug Resist Updat. 2006 Feb-Apr;9(1-2):26-39. doi: 10.1016/j.drup.2006.04.001. Drug Resist Updat. 2006. PMID: 16814199 Review.
-
The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.Expert Opin Drug Discov. 2020 Jun;15(6):647-658. doi: 10.1080/17460441.2020.1743674. Epub 2020 Mar 23. Expert Opin Drug Discov. 2020. PMID: 32202449 Review.
Cited by
-
Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series.Microorganisms. 2021 Jun 29;9(7):1408. doi: 10.3390/microorganisms9071408. Microorganisms. 2021. PMID: 34210040 Free PMC article.
-
Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance.Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00152-20. doi: 10.1128/AAC.00152-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32601168 Free PMC article.
-
Interferon Alpha Favors Macrophage Infection by Visceral Leishmania Species Through Upregulation of Sialoadhesin Expression.Front Immunol. 2020 Jun 9;11:1113. doi: 10.3389/fimmu.2020.01113. eCollection 2020. Front Immunol. 2020. PMID: 32582193 Free PMC article.
-
Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection.Parasit Vectors. 2020 Feb 22;13(1):96. doi: 10.1186/s13071-020-3972-z. Parasit Vectors. 2020. PMID: 32087758 Free PMC article.
-
In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates.PLoS Negl Trop Dis. 2019 Dec 2;13(12):e0007885. doi: 10.1371/journal.pntd.0007885. eCollection 2019 Dec. PLoS Negl Trop Dis. 2019. PMID: 31790397 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources